HOSPIRA PAPAVERINE HYDROCHLORIDE INJECTION papaverine hydrochloride 120 mg/10 mL injection ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

hospira papaverine hydrochloride injection papaverine hydrochloride 120 mg/10 ml injection ampoule

pfizer australia pty ltd - papaverine hydrochloride -

HOSPIRA PAPAVERINE HYDROCHLORIDE INJECTION papaverine hydrochloride 30 mg/1 mL injection ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

hospira papaverine hydrochloride injection papaverine hydrochloride 30 mg/1 ml injection ampoule

pfizer australia pty ltd - papaverine hydrochloride -

CISATRACURIUM ACCORD cisatracurium (as besilate) 150 mg / 30 mL solution for injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

cisatracurium accord cisatracurium (as besilate) 150 mg / 30 ml solution for injection vial

accord healthcare pty ltd - cisatracurium besilate, quantity: 201 mg (equivalent: cisatracurium, qty 150 mg) - injection, solution - excipient ingredients: benzenesulfonic acid; water for injections - indicated for use during surgical and other procedures and in intensive care to relax skeletal muscles, and to facilitate tracheal intubation and mechanical ventilation. it is used as an adjunct to general anaesthesia, or sedation in the intensive care unit

CISATRACURIUM ACCORD cisatracurium (as besilate) 5 mg /2.5 mL solution for injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

cisatracurium accord cisatracurium (as besilate) 5 mg /2.5 ml solution for injection vial

accord healthcare pty ltd - cisatracurium besilate, quantity: 6.7 mg (equivalent: cisatracurium, qty 5 mg) - injection, solution - excipient ingredients: water for injections; benzenesulfonic acid - indicated for use during surgical and other procedures and in intensive care to relax skeletal muscles, and to facilitate tracheal intubation and mechanical ventilation. it is used as an adjunct to general anaesthesia, or sedation in the intensive care unit

CISATRACURIUM ACCORD cisatracurium (as besilate) 20 mg /10 mL solution for injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

cisatracurium accord cisatracurium (as besilate) 20 mg /10 ml solution for injection vial

accord healthcare pty ltd - cisatracurium besilate, quantity: 26.8 mg (equivalent: cisatracurium, qty 20 mg) - injection, solution - excipient ingredients: water for injections; benzenesulfonic acid - indicated for use during surgical and other procedures and in intensive care to relax skeletal muscles, and to facilitate tracheal intubation and mechanical ventilation. it is used as an adjunct to general anaesthesia, or sedation in the intensive care unit

CISATRACURIUM ACCORD cisatracurium (as besilate) 50 mg / 25 mL solution for injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

cisatracurium accord cisatracurium (as besilate) 50 mg / 25 ml solution for injection vial

accord healthcare pty ltd - cisatracurium besilate, quantity: 67 mg (equivalent: cisatracurium, qty 50 mg) - injection, solution - excipient ingredients: benzenesulfonic acid; water for injections - indicated for use during surgical and other procedures and in intensive care to relax skeletal muscles, and to facilitate tracheal intubation and mechanical ventilation. it is used as an adjunct to general anaesthesia, or sedation in the intensive care unit

CISATRACURIUM ACCORD cisatracurium (as besilate) 10 mg / 5 mL solution for injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

cisatracurium accord cisatracurium (as besilate) 10 mg / 5 ml solution for injection vial

accord healthcare pty ltd - cisatracurium besilate, quantity: 13.4 mg (equivalent: cisatracurium, qty 10 mg) - injection, solution - excipient ingredients: water for injections; benzenesulfonic acid - indicated for use during surgical and other procedures and in intensive care to relax skeletal muscles, and to facilitate tracheal intubation and mechanical ventilation. it is used as an adjunct to general anaesthesia, or sedation in the intensive care unit

BRIDION SOLUTION Canada - English - Health Canada

bridion solution

merck canada inc - sugammadex (sugammadex sodium) - solution - 100mg - sugammadex (sugammadex sodium) 100mg - antidotes

DBL CISATRACURIUM INJECTION CONCENTRATE cisatracurium (as besilate) 10 mg/5 mL solution for injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

dbl cisatracurium injection concentrate cisatracurium (as besilate) 10 mg/5 ml solution for injection vial

pfizer australia pty ltd - cisatracurium besilate -

DBL CISATRACURIUM INJECTION CONCENTRATE cisatracurium (as besilate) 5 mg/2.5 mL solution for injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

dbl cisatracurium injection concentrate cisatracurium (as besilate) 5 mg/2.5 ml solution for injection vial

pfizer australia pty ltd - cisatracurium besilate -